Relationship of Glycated Albumin to Blood Glucose and HbA1c Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The association of chronic glycemia, measured by HbA1c, with long-term complications of type 1 diabetes has been well established in the Diabetes Control and Complications Trial (DCCT) and other studies. The role of intermediate-term and acute glycemia and of glucose variability on microvascular and cardiovascular disease (CVD) is less clear. In order to examine the interrelationships among long-term, intermediate-term, and acute measures of glucose and its daily variability, we compared HbA1c, glycated albumin (GA), and seven-point glucose profile concentrations measured longitudinally in a case-cohort subpopulation of the DCCT. HbA1c and GA were closely correlated with each other and with the mean blood glucose (MBG) calculated from the seven-point profile. The associations of glucose variability and postprandial concentrations with HbA1c and GA were relatively weak and were further attenuated when MBG was included in multivariate models. In the case-cohort analyses, HbA1c and GA had similar associations with retinopathy and nephropathy, which were strengthened when both measures were considered together. Only HbA1c was significantly associated with CVD. The demonstrated interrelationships among different measures of glycemia will need to be considered in future analyses of their roles in the development of long-term complications of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Few published studies have convincingly demonstrated a relationship between glycated protein levels and the chronic complications of diabetes (317).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [317]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum gly- cated protein assays (fructosamine and glycated albumin) may also be useful for glycemic monitoring in conjunction with other measures (see Section 6, “Glycemic Goals and Hypoglycemia”) (56)(57)(58)(59)(60).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [58]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationMultiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
A generalization of sampling without replacement from a finite universe
Horvitz, D. G., & Thompson, D. J. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483446 · Cited by 4,293
A Generalization of Sampling Without Replacement From a Finite Universe
Horvitz, D. G., & Thompson, D. J. (1952) · Journal of the American Statistical Association · doi:10.2307/2280784 · Cited by 3,011
The Robust Inference for the Cox Proportional Hazards Model
Lin, D. Y., & Wei, L. J. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478874 · Cited by 2,695
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
A multivariate technique for multiply imputing missing values using a sequence of regression models
Raghunathan, T. E., Lepkowski, J. M., Hoewyk, J. V., & Solenberger, P. W. (2001) · Survey methodology · Cited by 2,436
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Self-citationTranslating the A1C assay into estimated average glucose values
Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., Heine, R. J., & for the A1c-Derived Average Glucose (ADAG) Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0545 · Cited by 1,812
Self-citation(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
A case-cohort design for epidemiologic cohort studies and disease prevention trials
PRENTICE, R. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.1 · Cited by 1,439
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Self-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Multiple Imputation for Interval Estimation from Simple Random Samples with Ignorable Nonresponse
Rubin, D. B., & Schenker, N. (1986) · Journal of the American Statistical Association · doi:10.1080/01621459.1986.10478280 · Cited by 766
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653
An R2 statistic for fixed effects in the linear mixed model
Edwards, L. J., Muller, K. E., Wolfinger, R. D., Qaqish, B. F., & Schabenberger, O. (2008) · Statistics in Medicine · doi:10.1002/sim.3429 · Cited by 627
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Self-citationRobust Variance Estimation for the Case-Cohort Design
Barlow, W. E. (1994) · Biometrics · doi:10.2307/2533444 · Cited by 540
Albers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
Self-citationThe Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2006) · Diabetes Care · doi:10.2337/dc06-0293 · Cited by 377
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I. (2008) · Kidney International · doi:10.1038/ki.2008.25 · Cited by 323
Wadén, J., Forsblom, C., Thorn, L. M., Gordin, D., Saraheimo, M., Groop, P.-H., & on behalf of the Finnish Diabetic Nephropathy Study Group (2009) · Diabetes · doi:10.2337/db09-0693 · Cited by 239
YOSHIUCHI, K., MATSUHISA, M., KATAKAMI, N., NAKATANI, Y., SAKAMOTO, K., MATSUOKA, T., UMAYAHARA, Y., KOSUGI, K., KANETO, H., YAMASAKI, Y., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-089 · Cited by 194
Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications
Hirsch, I. B. (2010) · JAMA · doi:10.1001/jama.2010.785 · Cited by 184
Computing the Cox Model for Case Cohort Designs
Therneau, T. M., & Li, H. (1999) · Lifetime Data Analysis · doi:10.1023/a:1009691327335 · Cited by 164
Kouzuma, T., Uemastu, Y., Usami, T., & Imamura, S. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.019 · Cited by 163
McCarter, R. J., Hempe, J. M., & Chalew, S. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1594 · Cited by 126
Nontraditional Markers of Glycemia
Selvin, E., Francis, L. M. A., Ballantyne, C. M., Hoogeveen, R. C., Coresh, J., Brancati, F. L., & Steffes, M. W. (2011) · Diabetes Care · doi:10.2337/dc10-1945 · Cited by 125
Self-citationSteffes, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042143 · Cited by 125 · cited 1×
“HbA1c was measured quarterly during the DCCT and annually during EDIC using a high-precision, highperformance liquid chromatography assay with long-term control subjects to monitor assay stability as previously described (18).”
MethodSelf-citationService, F. J., & O'Brien, P. C. (2001) · Diabetologia · doi:10.1007/s001250100635 · Cited by 106
Furusyo, N., Koga, T., Ai, M., Otokozawa, S., Kohzuma, T., Ikezaki, H., Schaefer, E. J., & Hayashi, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.045 · Cited by 61
Determining Stability of Stored Samples Retrospectively: The Validation of Glycated Albumin
Nathan, D. M., Steffes, M. W., Sun, W., Rynders, G. P., & Lachin, J. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150250 · Cited by 56
Self-citationLachin, J. M. (2007) · Statistics in Medicine · doi:10.1002/sim.3057 · Cited by 53
Self-citationLachin, J. M. (2018) · Statistics in Medicine · doi:10.1002/sim.7598 · Cited by 42
Self-citationQuantitative Aspects of Labile Diabetes
Molnar, G. D., Gastineau, C. F., Rosevear, J. W., & Moxness, K. E. (1965) · Diabetes · doi:10.2337/diab.14.5.279 · Cited by 30
Research works printed but not linked: 1
- Nagamine, 2004, Evaluation of the enzymatic method for glycated albumin with liquid type reagent (Lucia GA-L), Jpn J Med Pharm Sci, 51, 737
Cited by
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Beck, R. W., Bergenstal, R. M., Riddlesworth, T. D., Kollman, C., Li, Z., Brown, A. S., & Close, K. L. (2019) · Diabetes Care · doi:10.2337/dc18-1444 · Cited by 793
DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 486
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Metadata
- Authors
- Nathan, D. M., McGee, P., Steffes, M. W., Lachin, J. M., & the DCCT/EDIC Research Group
- Affiliations
- Harvard University (US)
- George Washington University (US)
- University of Minnesota (US)
- Corresponding author
- McGee, Paula
- ORCID
- Lachin, John M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2013-12-13
- Volume
- 63
- Issue
- 1
- Pages
- 282-290
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3868040
- OpenAlex
- W2139557453
- Semantic Scholar
- fc7f986f4b37cab94f3e11016a32ca455c15e3e6
- Cited by
- 214
- References
- 37
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 14 · 2023: 19 · 2022: 19 · 2021: 9 · 2020: 19 · 2019: 16 · 2018: 24 · 2017: 23 · 2016: 22 · 2015: 14 · 2014: 20 · 2013: 4
- FWCI
- 15.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000041, UL1TR001449)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- glycated albumin, HbA1c, blood glucose, glycemic variability, type 1 diabetes, diabetic retinopathy, diabetic nephropathy, cardiovascular disease, microvascular complications, mean blood glucose, postprandial blood glucose, DCCT/EDIC
- MeSH terms
- Glycated Serum Albumin, Adolescent, Adult, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Retinopathy, Glycated Hemoglobin, Humans, Serum Albumin, Severity of Illness Index, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.